OSC case against Grant Sanders, ex-CEO of cannabis company Instadose Pharma, thrown out over long delay

Sverige Nyheter Nyheter

OSC case against Grant Sanders, ex-CEO of cannabis company Instadose Pharma, thrown out over long delay
Sverige Senaste nytt,Sverige Rubriker

In a statement, the OSC declined to comment on allegations that its case against the former Instadose chairman was flawed

  • 📰 globebusiness
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 66%

A fraud charge against the former chairman and chief executive officer of Instadose Pharma Corp. has been stayed in Ontario court over excessive delays, marking another blow to the Ontario Securities Commission’s enforcement branch.

“The original investigation was flawed, hurried and incomplete. The stay for delay was the legally correct decision but also a fitting end to a very weak case,” he said. Mr. Sanders was charged by the regulator with a quasi-criminal offence in July, 2021. When the OSC identifies wrongdoing, it has the option of prosecuting cases in provincial court or as a regulatory matter. Offences dealt with in provincial court are quasi-criminal and carry larger penalties, including the potential for jail time.

Since the OSC launched its case, Instadose has been taken private, with former shareholders being able to exchange their shares on a one-for-one basis.

Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

globebusiness /  🏆 31. in SE
 

Sverige Senaste nytt, Sverige Rubriker

Similar News:Du kan också läsa nyheter som liknar den här som vi har samlat in från andra nyhetskällor.

OSC probes Emerge Canada after investment manager shut down fundsOSC probes Emerge Canada after investment manager shut down fundsInvestor advocate says unitholders should question where auditor, regulators were as Emerge’s financial condition declined
Läs mer »



Render Time: 2025-01-13 16:57:20